ArticleNaunyn-Schmiedeberg's archives of pharmacology2020

The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways.

Mohamed Abd-Elbaset et al.PubMed ↗Publisher ↗

No numbers read from the abstract.